Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya

• Deron C. Burton ,

  * E-mail: DBurton@cdc.gov

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Godfrey M. Bigogo,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Allan O. Audi,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• John Williamson,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, Center for Global Health, CDC, Atlanta, Georgia, United States of America

  ⨯
• Kenneth Munge,

  Affiliation KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

  ⨯
• Jackline Wafula,

  Affiliation KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

  ⨯
• Dominic Ouma,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Sammy Khagayi,

  Affiliation Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya

  ⨯
• Isaac Mugoya,

  Affiliation Division of Vaccines and Immunization, Ministry of Public Health and Sanitation, Nairobi, Kenya

  ⨯
• James Mburu,

  Affiliation KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

  ⨯
• Shadrack Muema,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Evasius Bauni,

  Affiliation KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

  ⨯
• Tahreni Bwanaali,

  Affiliation KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

  ⨯
• Daniel R. Feikin,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Peter M. Ochieng,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Ondari D. Mogeni,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• George A. Otieno,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Beatrice Olack,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Tatu Kamau,

  Affiliation Division of Vaccines and Immunization, Ministry of Public Health and Sanitation, Nairobi, Kenya

  ⨯
• Melissa K. Van Dyke,

  Affiliation GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• Robert Chen,

  Affiliation National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, Georgia, United States of America

  ⨯
• Paddy Farrington,

  Affiliation Open University, Buckinghamshire, United Kingdom

  ⨯
• Joel M. Montgomery,

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya

  ⨯
• Robert F. Breiman,

  Affiliations International Emerging Infections Program, Global Disease Detection Response Center, CDC, Kisumu and Nairobi, Kenya, Center for Global Health, CDC, Atlanta, Georgia, United States of America

  ⨯
• J. Anthony G. Scott,

  Affiliations KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya, London School of Hygiene & Tropical Medicine, London, United Kingdom

  ⨯
•  [ ... ],
• Kayla F. Laserson

  Affiliations Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health Collaboration, Kisumu and Nairobi, Kenya, Center for Global Health, CDC, Atlanta, Georgia, United States of America

  ⨯
• [ view all ]
• [ view less ]